Resultados de procura - Anusha Kalbasi

Limitar resultados
  1. 1
    Tumour-intrinsic resistance to immune checkpoint blockade

    Tumour-intrinsic resistance to immune checkpoint blockade por Anusha Kalbasi, Antoni Ribas

    Publicado 2019
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  2. 2
    Radiation and immunotherapy: a synergistic combination

    Radiation and immunotherapy: a synergistic combination por Anusha Kalbasi, Carl H. June, Naomi B. Haas, Neha Vapiwala

    Publicado 2013
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  3. 3
    Prediction of SARS-CoV-2 epitopes across 9360 HLA class I alleles.

    Prediction of SARS-CoV-2 epitopes across 9360 HLA class I alleles. por Katie M. Campbell, Gabriela Steiner, Daniel K. Wells, Antoni Ribas, Anusha Kalbasi

    Publicado 2020
    Ligazón do recurso
    Pré-impressão
    Engadir a favoritos
    Gardado en:
  4. 4
    Prioritization of SARS-CoV-2 epitopes using a pan-HLA and global population inference approach

    Prioritization of SARS-CoV-2 epitopes using a pan-HLA and global population inference approach por Katie M. Campbell, Gabriela Steiner, Daniel K. Wells, Antoni Ribas, Anusha Kalbasi

    Publicado 2020
    Ligazón do recurso
    Pré-impressão
    Engadir a favoritos
    Gardado en:
  5. 5
    Low rates of adjuvant radiation in patients with nonmetastatic prostate cancer with high‐risk pathologic features

    Low rates of adjuvant radiation in patients with nonmetastatic prostate cancer with high‐risk pathologic features por Anusha Kalbasi, Samuel Swisher‐McClure, Nandita Mitra, R. Sunderland, Marc C. Smaldone, Robert G. Uzzo, Justin E. Bekelman

    Publicado 2014
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    Tumor-Derived CCL2 Mediates Resistance to Radiotherapy in Pancreatic Ductal Adenocarcinoma

    Tumor-Derived CCL2 Mediates Resistance to Radiotherapy in Pancreatic Ductal Adenocarcinoma por Anusha Kalbasi, Chad A. Komar, Graham M. Tooker, Mingen Liu, Jae W. Lee, Whitney L. Gladney, Edgar Ben‐Josef, Gregory L. Beatty

    Publicado 2016
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    Dose-Escalated Irradiation and Overall Survival in Men With Nonmetastatic Prostate Cancer

    Dose-Escalated Irradiation and Overall Survival in Men With Nonmetastatic Prostate Cancer por Anusha Kalbasi, Jiaqi Li, Abigail T. Berman, Samuel Swisher‐McClure, Marc C. Smaldone, Robert G. Uzzo, Dylan S. Small, Nandita Mitra, Justin E. Bekelman

    Publicado 2015
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  8. 8
    Antitumor Immune Responses in <i>B2M</i>-Deficient Cancers

    Antitumor Immune Responses in <i>B2M</i>-Deficient Cancers por Davis Y. Torrejon, Mildred Galvez, Gabriel Abril-Rodríguez, Katie M. Campbell, Egmidio Medina, Agustin Vega-Crespo, Anusha Kalbasi, Begoña Comı́n-Anduix, Antoni Ribas

    Publicado 2023
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study

    SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study por Antoni Ribas, Theresa Medina, Shivaani Kummar, Asim Amin, Anusha Kalbasi, Joseph J. Drabick, Minal Barve, Gregory A. Daniels, Deborah Jean Lee Wong, Emmett V. Schmidt, Albert F. Candia, Robert L. Coffman, Abraham C.F. Leung, Robert Janssen

    Publicado 2018
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    A novel multiplex assay combining autoantibodies plus PSA has potential implications for classification of prostate cancer from non-malignant cases

    A novel multiplex assay combining autoantibodies plus PSA has potential implications for classification of prostate cancer from non-malignant cases por Chong Xie, Grace Hyun J. Kim, Jonathan G Haw, Anusha Kalbasi, Brian Gardner, Gang Li, Jianyu Rao, David Chia, Monty Liong, Rubio Punzalan, Leonard S. Marks, Allan J. Pantuck, Alexandre de la Taille, Guomin Wang, Hideki Mukouyama, Gang Zeng

    Publicado 2011
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    A Phase II Trial of 5-Day Neoadjuvant Radiotherapy for Patients with High-Risk Primary Soft Tissue Sarcoma

    A Phase II Trial of 5-Day Neoadjuvant Radiotherapy for Patients with High-Risk Primary Soft Tissue Sarcoma por Anusha Kalbasi, Mitchell Kamrava, Fang‐I Chu, Donatello Telesca, Ritchell van Dams, Yingli Yang, Dan Ruan, Scott D. Nelson, Sarah Dry, Jackie Hernandez, Bartosz Chmielowski, Arun S. Singh, Susan V. Bukata, Nicholas M. Bernthal, Michael L. Steinberg, Joanne B. Weidhaas, Fritz C. Eilber

    Publicado 2020
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    Treatment effect prediction for sarcoma patients treated with preoperative radiotherapy using radiomics features from longitudinal diffusion-weighted MRIs

    Treatment effect prediction for sarcoma patients treated with preoperative radiotherapy using radiomics features from longitudinal diffusion-weighted MRIs por Yu Gao, Anusha Kalbasi, William Hsu, Dan Ruan, Jie Fu, Jiaxin Shao, Minsong Cao, Chenyang Wang, Fritz C. Eilber, Nicholas M. Bernthal, Susan V. Bukata, Sarah Dry, Scott D. Nelson, Mitchell Kamrava, John H. Lewis, Daniel A. Low, Michael L. Steinberg, Peng Hu, Yingli Yang

    Publicado 2020
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma

    Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma por Anusha Kalbasi, Mito Tariveranmoshabad, Kevin Hakimi, Sarah Kremer, Katie M. Campbell, Juan M. Funes, Agustin Vega-Crespo, Giulia Parisi, Ameya Champekar, Christine Nguyen, Davis Y. Torrejon, Daniel Sanghoon Shin, Jesse M. Zaretsky, Robert Damoiseaux, Daniel E. Speiser, Pedro P. López‐Casas, Marisol Quintero, Antoni Ribas

    Publicado 2020
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  14. 14
    Long-term Outcomes With Ifosfamide-based Hypofractionated Preoperative Chemoradiotherapy for Extremity Soft Tissue Sarcomas

    Long-term Outcomes With Ifosfamide-based Hypofractionated Preoperative Chemoradiotherapy for Extremity Soft Tissue Sarcomas por J.D.D. Pennington, Fritz C. Eilber, Frederick R. Eilber, Arun S. Singh, Jarred P. Reed, Bartosz Chmielowski, Jeffrey J. Eċkardt, Susan V. Bukata, Nicholas M. Bernthal, Noah Federman, Scott D. Nelson, Sarah Dry, Pin‐Chieh Wang, Michael Luu, Michael T. Selch, Michael L. Steinberg, Anusha Kalbasi, Mitchell Kamrava

    Publicado 2018
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  15. 15
    A Pilot Trial of the Combination of Transgenic NY-ESO-1–reactive Adoptive Cellular Therapy with Dendritic Cell Vaccination with or without Ipilimumab

    A Pilot Trial of the Combination of Transgenic NY-ESO-1–reactive Adoptive Cellular Therapy with Dendritic Cell Vaccination with or without Ipilimumab por Theodore S. Nowicki, Beata Berent-Maoz, Gardenia Cheung-Lau, Rong Huang, Xiaoyan Wang, Jennifer Tsoi, Paula Kaplan‐Lefko, Paula Cabrera, Justin Tran, Jia Pang, Mignonette H. Macabali, Ivan Perez Garcilazo, Ignacio Baselga-Carretero, Anusha Kalbasi, Alistair J. Cochran, Catherine S. Grasso, Siwen Hu‐Lieskovan, Bartosz Chmielowski, Begoña Comı́n-Anduix, Arun D. Singh, Antoni Ribas

    Publicado 2018
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  16. 16
    PAK4 inhibition improves PD-1 blockade immunotherapy

    PAK4 inhibition improves PD-1 blockade immunotherapy por Gabriel Abril-Rodríguez, Davis Y. Torrejon, Wei Liu, Jesse M. Zaretsky, Theodore S. Nowicki, Jennifer Tsoi, Cristina Puig-Saus, Ignacio Baselga-Carretero, Egmidio Medina, Michael J. Quist, Alejandro J. Garcia, William Senapedis, Erkan Baloglu, Anusha Kalbasi, Gardenia Cheung-Lau, Beata Berent-Maoz, Begoña Comı́n-Anduix, Siwen Hu‐Lieskovan, Cun‐Yu Wang, Catherine S. Grasso, Antoni Ribas

    Publicado 2019
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  17. 17
    Overcoming Genetically Based Resistance Mechanisms to PD-1 Blockade

    Overcoming Genetically Based Resistance Mechanisms to PD-1 Blockade por Davis Y. Torrejon, Gabriel Abril-Rodríguez, Ameya S. Champhekar, Jennifer Tsoi, Katie M. Campbell, Anusha Kalbasi, Giulia Parisi, Jesse M. Zaretsky, Ángel García-Díaz, Cristina Puig-Saus, Gardenia Cheung-Lau, Thomas Wohlwender, Paige Krystofinski, Agustin Vega-Crespo, Christopher M. Lee, Pau Mascaro, Catherine S. Grasso, Beata Berent-Maoz, Begoña Comı́n-Anduix, Siwen Hu‐Lieskovan, Antoni Ribas

    Publicado 2020
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  18. 18
    Potentiating adoptive cell therapy using synthetic IL-9 receptors

    Potentiating adoptive cell therapy using synthetic IL-9 receptors por Anusha Kalbasi, Mikko Siurala, Leon Su, Mito Tariveranmoshabad, Lora K. Picton, Pranali Ravikumar, Peng Li, Jian‐Xin Lin, Helena Escuin-Ordinas, Tong Da, Sarah Kremer, Amy Sun, Sofia Castelli, Sangya Agarwal, John Scholler, Decheng Song, Philipp C. Rommel, Enrico Radaelli, Regina M. Young, Warren J. Leonard, Antoni Ribas, Carl H. June, K. Christopher García

    Publicado 2022
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  19. 19
    Primary Resistance to PD-1 Blockade Mediated by <i>JAK1/2</i> Mutations

    Primary Resistance to PD-1 Blockade Mediated by <i>JAK1/2</i> Mutations por Daniel Sanghoon Shin, Jesse M. Zaretsky, Helena Escuin-Ordinas, Ángel García-Díaz, Siwen Hu‐Lieskovan, Anusha Kalbasi, Catherine S. Grasso, Willy Hugo, Salemiz Sandoval, Davis Y. Torrejon, Nicolaos Palaskas, Gabriel Abril Rodriguez, Giulia Parisi, Ariel M. Azhdam, Bartosz Chmielowski, Grace Cherry, Elizabeth Seja, Beata Berent-Maoz, I. Peter Shintaku, Dung T. Le, Drew M. Pardoll, Luis A. Díaz, Paul C. Tumeh, Thomas G. Graeber, Roger S. Lo, Begoña Comı́n-Anduix, Antoni Ribas

    Publicado 2016
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  20. 20
    The landscape of drug sensitivity and resistance in sarcoma

    The landscape of drug sensitivity and resistance in sarcoma por Ahmad Al Shihabi, Peyton Tebon, Huyen Thi Lam Nguyen, Jomjit Chantharasamee, Sara Sartini, Ardalan Davarifar, Alexandra Y Jensen, Miranda Diaz-Infante, Hannah C. Cox, Alfredo Enrique Gonzalez, Summer Norris, Jantzen Sperry, Jonathan Nakashima, Nasrin Tavanaie, Helena Winata, Sorel Fitz‐Gibbon, Takafumi N. Yamaguchi, Jae Hoon Jeong, Sarah Dry, Arun S. Singh, Bartosz Chmielowski, Joseph G. Crompton, Anusha Kalbasi, Fritz C. Eilber, Francis J. Hornicek, Nicholas M. Bernthal, Scott D. Nelson, Paul C. Boutros, Noah Federman, Jane Yanagawa, Alice Soragni

    Publicado 2024
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: